CIK 0001661053
- Non-accelerated filer
- Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330936180
- Phone
- +1 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Glickman Marc H. SVP & Chief Medical Officer | Other disposition · Restricted Stock Units | −100,000 | 0 | ||
| 2024-12-18 | Glickman Marc H. SVP & Chief Medical Officer | Grant or award · Stock Options | +75,000 | 75,000 | ||
| 2023-12-05 | Glickman Marc H. SVP & Chief Medical Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2021-11-30 | Glickman Marc H. SVP & Chief Medical Officer | Grant or award | +100,000 | 101,600 | ||
| 2021-11-30 | Glickman Marc H. SVP & Chief Medical Officer | Grant or award · Stock Options | +265,700 | 265,700 | ||
| 2021-05-21 | Glickman Marc H. SVP & Chief Medical Officer | Purchase | +1,600 | $5.90 | $9K | 1,600 |
| 2021-02-18 | Glickman Marc H. SVP & CMO | Grant or award · Stock Option | +406,000 | 406,000 | ||
| 2020-07-18 | Glickman Marc H. SVP & CMO | Grant or award · Stock Option | +1,000,000 | 1,000,000 | ||
| 2019-07-26 | Glickman Marc H. CMO and Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −184,500 | 0 | ||
| 2019-07-26 | Glickman Marc H. CMO and Senior Vice President | Grant or award · Stock Option (Right to Buy) | +184,500 | 184,500 | ||
| 2019-07-26 | Glickman Marc H. CMO and Senior Vice President | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 |
Page 1 of 1 · 11 trades